The client, with an established national field sales footprint, looked to partner to improve the stagnant sales trajectory for their I/O delivery device.
A field team of 16 DSAs (diabetes representatives) was overlayed to existing team to support high and medium-value targets to improve impact and call frequency.
DSAs’ goals also included elevating brand perception not just to the targeted HCPs but through a total account call to maximize pull-through adjacent to clinical selling.
Within the first four months of the added team, high-value DSA targets were averaging 3.5 more Rxs per target compared to the control group.
Average DSA had 21% more call activity (and 12% more sampling) than incumbent team.
Call activity (reach and frequency) was improved while contributing to a significant improvement in the cost per call (82% savings) for DSA targets.
Qualitative (market effectiveness surveys) feedback also showed improved brand and message recall and DSA satisfaction.
Wave 1:
93% of respondents state that they are ‘very satisfied’ with their DSA.**
**7% state that they are ‘satisfied’.
Jump to a slide with the slide dots.
CASE STUDY (US) Collaborative inside sales solution delivers 4-to-1 impact for newly approved rheumatology product over three years.
Read moreCASE STUDY (US) Inside Regional Account Managers surpass sales by 178% for specialty product, by targeting an untapped market.
Read moreCASE STUDY (US) Call center engagement themes identified through speech analytics insights.
Read more